These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 128684

  • 21. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L, Dordoni D, Gastaldi C, Gastaldi A.
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of hirsutism and acne. Sequential inverse therapy with anti-androgen-estrogen].
    Lebeau M, Vokaer R.
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(7):715-21. PubMed ID: 4267704
    [No Abstract] [Full Text] [Related]

  • 23. [Use of anti-androgens in skin diseases].
    Nolting S.
    Z Hautkr; 1979 Jun 15; 54(12):529-32. PubMed ID: 88827
    [No Abstract] [Full Text] [Related]

  • 24. [A new ovulation inhibitor antiandrogen].
    Millet-part A, Blanes-espi A, Ferrer-barriendos J, Siqueira L, Acosta E.
    J Bras Ginecol; 1984 Mar 15; 94(3):91-7. PubMed ID: 12266391
    [Abstract] [Full Text] [Related]

  • 25. [Treatment of acne, hirsutism and alopecia, by cyproterone acetate and ethinyl estradiol].
    Neale C, Krebs D, Bettendorf G.
    Acta Endocrinol Suppl (Copenh); 1971 Mar 15; 152():13. PubMed ID: 4251532
    [No Abstract] [Full Text] [Related]

  • 26. [Differentiated application of oral contraceptives basing on the different side effects of synthetic progestins (author's transl)].
    Braendle W, Leidenberger F.
    Ther Umsch; 1976 Apr 15; 33(4):231-3. PubMed ID: 137547
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Treatment of hirsutism, acne and alopecia with cyproterone acetate.
    Ekoe JM, Burckhardt P, Ruedi B.
    Dermatologica; 1980 Apr 15; 160(6):398-404. PubMed ID: 6446466
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S, Layton A, Glasier A.
    Hum Reprod; 2008 Feb 15; 23(2):231-2. PubMed ID: 18083746
    [Abstract] [Full Text] [Related]

  • 31. [Antiandrogen treatment with cyproterone acetate in with virilizing symptoms].
    Abrahamsson L, Hackl H, Lindström B, Martinik J.
    Lakartidningen; 1981 Nov 18; 78(47):4259-61. PubMed ID: 6460145
    [No Abstract] [Full Text] [Related]

  • 32. [Medium-dose oral cyproterone acetate therapy in women with moderate androgenization. Results of a multicenter double-blind study].
    Moltz L, Kaiser E.
    Geburtshilfe Frauenheilkd; 1984 Jan 18; 44(1):47-52. PubMed ID: 6230282
    [Abstract] [Full Text] [Related]

  • 33. [Indications and limits of anti-androgen therapy].
    Zaun H.
    Z Hautkr; 1984 Aug 15; 59(16):1090-7. PubMed ID: 6207673
    [Abstract] [Full Text] [Related]

  • 34. [Effect and side-effect of cyproteron-acetat-treatment (author's transl)].
    Braendle W, Boess H, Breckwoldt M, Leven C, Bettendorf G.
    Arch Gynakol; 1974 Jul 05; 216(4):335-45. PubMed ID: 4277171
    [No Abstract] [Full Text] [Related]

  • 35. [Long-term treatment of virilized women with cyproterone acetate (author's transl)].
    Abrahamsson L, Hackl H, Lindström B, Sogn J.
    Wien Klin Wochenschr; 1981 Sep 18; 93(17):552-6. PubMed ID: 6458162
    [Abstract] [Full Text] [Related]

  • 36. [Hormonotherapy in acute, idiopathic hirsutism, and seborrheic alopecia (author's transl)].
    Belaube P, Devaux J, Gamby T, Garcin G, Privat Y.
    Sem Hop; 1982 Jul 01; 58(26-27):1650-3. PubMed ID: 6287643
    [Abstract] [Full Text] [Related]

  • 37. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Evaluation of the clinical effect].
    Pedersen IM, Nielsen DR, Larsen J, Starup J.
    Ugeskr Laeger; 1985 Aug 12; 147(33):2594-6. PubMed ID: 2933858
    [No Abstract] [Full Text] [Related]

  • 38. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.
    Plewig G, Cunliffe WJ, Binder N, Höschen K.
    Contraception; 2009 Jul 12; 80(1):25-33. PubMed ID: 19501212
    [Abstract] [Full Text] [Related]

  • 39. [Therapy of androgenization symptoms: double blind study of an antiandrogen preparation (SH B 209 AB) against neogynon (author's transl)].
    Lachnit-Fixson U, Kaufmann J.
    Med Klin; 1977 Nov 11; 72(45):1922-6. PubMed ID: 144842
    [Abstract] [Full Text] [Related]

  • 40. [Use of cyproterone acetate in the treatment of acne].
    Piquero Martín J, Acosta H.
    Med Cutan Ibero Lat Am; 1982 Nov 11; 10(4):261-6. PubMed ID: 6222232
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.